CERE
Deutsche Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,925
| Closed | -$242K | – | 3603 |
|
|
2024
Q2 | $242K | Sell |
5,925
-566,542
| -99% | -$23.2M | ﹤0.01% | 2665 |
|
|
2024
Q1 | $24.2M | Buy |
572,467
+210,053
| +58% | +$8.88M | 0.01% | 753 |
|
|
2023
Q4 | $15.4M | Buy |
362,414
+328,487
| +968% | +$13.9M | 0.01% | 857 |
|
|
2023
Q3 | $741K | Buy |
33,927
+4,599
| +16% | +$100K | ﹤0.01% | 1888 |
|
|
2023
Q2 | $932K | Sell |
29,328
-12,005
| -29% | -$382K | ﹤0.01% | 2029 |
|
|
2023
Q1 | $1.01M | Buy |
41,333
+11,535
| +39% | +$281K | ﹤0.01% | 2098 |
|
|
2022
Q4 | $940K | Buy |
29,798
+4,899
| +20% | +$155K | ﹤0.01% | 2096 |
|
|
2022
Q3 | $704K | Sell |
24,899
-7,288
| -23% | -$206K | ﹤0.01% | 2182 |
|
|
2022
Q2 | $850K | Buy |
32,187
+5,806
| +22% | +$153K | ﹤0.01% | 2277 |
|
|
2022
Q1 | $924K | Sell |
26,381
-1,963
| -7% | -$68.8K | ﹤0.01% | 2391 |
|
|
2021
Q4 | $919K | Buy |
28,344
+1,875
| +7% | +$60.8K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $781K | Buy |
26,469
+4,021
| +18% | +$119K | ﹤0.01% | 2762 |
|
|
2021
Q2 | $575K | Buy |
+22,448
| New | +$575K | ﹤0.01% | 3116 |
|